新近研究表明,功能性消化不良患者多数有胃运动障碍、胃排空延迟。为此,我们观察了西沙必利对功能性消化不良的疗效和耐受性。 资料分析:将临床确诊为功能性消化不良的39例患者随机分为西沙必利治疗组(24例)和安慰剂组(15例)。治疗组每次饭前口服西沙必利5mg,每日3次。将所有症状分为0(无症状),十(轻度,稍加注意就感到有症状存在),卄(中度,自觉有症状,但不影响工作或症状介于轻、重度之间),卅(重度,发作时不能坚持工作)。在用药2周和4周后统计疗效,即显效(症状完全缓解或改善2个 Recent studies have shown that most patients with functional dyspepsia gastric motility disorders, delayed gastric emptying. To this end, we have observed the efficacy and tolerability of cisapride against functional dyspepsia. DATA ANALYSIS: Thirty-nine patients with clinically diagnosed functional dyspepsia were randomized to cisapride (n = 24) and placebo (n = 15). The treatment group oral cisapride 5mg before meals, 3 times a day. All symptoms were classified as 0 (asymptomatic), 10 (mild, slightly symptomatic), 卄 (moderate, conscious with symptoms but without affecting work or symptoms between mild and severe),卅 (severe, can not persist in the attack work). After 2 weeks and 4 weeks after treatment, the effect was statistically significant (symptoms completely relieved or improved 2)